Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004220 · ClinicalTrials.gov registry record · Phase 1
Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer
A Phase 1 study, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00004220: Completed Phase 1 study, sponsored by City of Hope Medical Center.
NCT00004220 is a Phase 1 study that has completed, run by City of Hope Medical Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004220, a Phase 1 study, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of oxaliplatin and gemcitabine in treating patients who have advanced cancer.
Interventions
- DRUG oxaliplatin
- DRUG gemcitabine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-10 |
| Phase | Phase 1 |
What the finished NCT00004220 record still lists
NCT00004220 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which oxaliplatin is the first listed.
NCT00004220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004220 about?
NCT00004220 is a clinical study titled "Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of oxaliplatin and gemcitabine in treating patients who have advanced can...
What is the current status of trial NCT00004220?
This trial is currently completed. It is a Phase 1 study. The study started on 1999-10.
What interventions are being tested in trial NCT00004220?
The interventions under investigation include: oxaliplatin (DRUG), gemcitabine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00004220?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia